Evidence map›Paper›PMID 33192085›Full record

ArticleInternational journal of nephrology and renovascular disease2020

Advanced Chronic Kidney Disease is a Strong Predictor of Hypogonadism and is Associated with Decreased Lean Tissue Mass.

Ryszard Skiba, Anna Matyjek, Tomasz Syryło, Stanisław Niemczyk, Aleksandra Rymarz

Open access · goldAbstract read
In one paragraph

Article in International journal of nephrology and renovascular disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?Journal of cachexia, sarcopenia and muscle · 2025
    Review
  4. Review
  5. Article
  6. Cellular senescence in brain aging and cognitive decline.Frontiers in aging neuroscience · 2023
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryszard SkibaDepartment of General, Functional and Oncological Urology, Military Institute of Medicine, Warsaw, Poland.ORCID 0000-0001-9342-7270
Anna MatyjekDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Tomasz SyryłoDepartment of General, Functional and Oncological Urology, Military Institute of Medicine, Warsaw, Poland.ORCID 0000-0002-5537-1373
Stanisław NiemczykDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.ORCID 0000-0001-8151-860X
Aleksandra RymarzDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.ORCID 0000-0002-1844-9872
Wojskowy Instytut Medycyny Lotniczej · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn patients with chronic kidney disease (CKD), hypogonadism is more frequent than in the general population and its prevalence ranges between 40% and 60%. The aim of the study was to investigate the prevalence of hypogonadism and its association with kidney function, body composition, inflammatory markers and lipid disorders in patients with CKD. MATERIALS AND

methodsThe study population consisted of 112 men aged ≥40 years in different stages of CKD: 33 participants with eGFR ≥60 mL/min/1.73 m

resultsCKD stage was a strong predictor of hypogonadism (providing an information value of 0.83). The weight of evidence technique allowed us to differentiate the high-risk group, which was a group of patients with advanced CKD, defined as eGFR <30 mL/min/1.73 m

conclusionDecreased eGFR and decreased LTI are predictors of hypogonadism associated with CKD. The study results suggest that hypogonadism screening should be carried out when eGFR deceases below 30 mL/min/1.73 m

Indexed as

chronic kidney diseasefree testosteronehypogonadismlean tissue indextotal testosterone

Identifiers

PMID33192085
PMCPMC7653405
OpenAlexW3097105793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.